Axcella Therapeutics
Company · Cambridge, United States
Website: axcellatx.com. US biotech whose drug AXA1125 was tested in an Oxford-led long COVID phase 2a trial.
Activity not confirmed in the last 12 months, checked October 18, 2026.
1 relationship with other organizations documented in IE research. Members see who they are and the evidence.
In context
Axcella Therapeutics is one of 898 companies in the United States listed in the Innovative EcoSystems registry.
Companies active in the regional innovation ecosystem, as partners, customers, employers or investors.
The United States scores 68.5 out of 100 on the IEPA (2024 edition), ranking 21 of 117 economies.
See the United States on the IEPA ↗
More companies in the United States
- Waker Group
Columbus - Vertical Bridge
Delray Beach - Baptist Health Medical Center – Magnolia
Magnolia - Updox
Dublin - Stirling Ultracold
Athens - IMT Insurance
West Des Moines - Heartland Financial USA (HTLF)
Dubuque · Closed - Veeam Software
Columbus